4 things to know about the new sunscreen ingredient the FDA approved

news.ycombinator.com

Image Credit: news.ycombinator.com

Please find more details at news.ycombinator.com

Summary

The Food and Drug Administration approved a new sunscreen ingredient in the U.S. for the first time in 20 years. Its been used for decades in Europe and Asia.

Source: news.ycombinator.com

Read More

(0)

AI News Q&A (Free Content)

This content is freely available. No login required. Disclaimer: Following content is AI generated from various sources including those identified below. Always check for accuracy. No content here is an advice. Please use the contact button to share feedback about any inaccurate content generated by AI. We sincerely appreciate your help in this regard.

Q1: What is the significance of the FDA's approval of bemotrizinol as a new sunscreen ingredient?

A1: The FDA's approval of bemotrizinol is significant as it marks the first time in over 20 years that a new sunscreen ingredient has been approved in the U.S. Bemotrizinol, which has been widely used in Europe and Asia, offers broad-spectrum protection against UVA and UVB rays, making it a safer and more effective option compared to many existing chemical sunscreen ingredients. This approval is expected to enhance consumer confidence in sunscreen products and provide better sun protection.

Q2: How does bemotrizinol contribute to sun protection, and why is it considered safer than other ingredients?

A2: Bemotrizinol is a broad-spectrum UV filter that blocks both UVA and UVB rays, which are responsible for skin damage and increased melanoma risk. It is considered safer because it has low levels of absorption through the skin, minimizing potential systemic exposure. Unlike some other chemical sunscreens that may enter the bloodstream, bemotrizinol remains stable under sunlight, providing consistent protection without breaking down easily.

Q3: What challenges did the FDA face in approving bemotrizinol, and how does this impact the sunscreen market?

A3: The FDA faced a lengthy regulatory review process, taking over two decades to approve bemotrizinol. This delay was partly due to stringent safety and efficacy evaluations required for new ingredients. The approval is expected to stimulate innovation in the sunscreen market, encouraging more efficient regulatory processes, and potentially leading to more diverse and competitive sunscreen products available to U.S. consumers.

Q4: What are the environmental and health implications of using novel sunscreen ingredients like bemotrizinol?

A4: Novel sunscreen ingredients like bemotrizinol are designed to provide effective protection against UV radiation while minimizing environmental and health impacts. Unlike some chemical sunscreens that may accumulate in aquatic ecosystems and enter the human bloodstream, bemotrizinol has low systemic absorption and is less likely to contribute to environmental pollution. This makes it a more sustainable and health-conscious choice for sun protection.

Q5: What recent scientific findings support the development of new sunscreen formulations, and how do they impact consumer choices?

A5: Recent scientific studies highlight the potential of combining natural bioactives with traditional sunscreen ingredients to enhance photoprotection and reduce skin damage. For instance, combinations of flavonoids and carotenoids have shown increased radical scavenging activity and reduced oxidative stress in skin cells. These findings support the development of more effective sunscreen formulations, offering consumers improved options for sun protection.

Q6: How do the optical properties of sunscreen ingredients affect their protective capabilities?

A6: The optical properties of sunscreen ingredients, such as their absorption and scattering coefficients, play a crucial role in their protective capabilities. Ingredients like titanium dioxide and zinc oxide scatter and absorb UV radiation, providing a physical barrier on the skin. Advances in understanding these properties enable the optimization of sunscreen formulations to maximize protection while minimizing cosmetic drawbacks, such as whitening effects on the skin.

Q7: What are the potential risks associated with the degradation of sunscreen ingredients, and how can they be mitigated?

A7: The degradation of sunscreen ingredients, such as 2-ethylhexyl-4-methoxycinnamate, can lead to the formation of harmful breakdown products, especially when exposed to chemicals like sodium hypochlorite. These risks can be mitigated by developing more stable sunscreen formulations and using ingredients like bemotrizinol that maintain their integrity under UV exposure. Additionally, regulatory measures and consumer education on proper sunscreen use can help minimize potential health risks.

References:

  • Sunscreen - Wikipedia
  • Morin and Morin Semicarbazone Combined with Fucoxanthin Have Potential Anti-Inflammaging Effects Through Modulation of Nrf2/HO-1 System in UVB-Exposed HaCaT Keratinocytes
  • Bemotrizinol FDA approval
  • Optics of sunscreen lotions: Preliminary results on scattering and absorption coefficients
  • Formation of chlorinated breakdown products during degradation of sunscreen agent, 2-ethylhexyl-4-methoxycinnamate in the presence of sodium hypochlorite
  • FDA approves new sunscreen ingredient used for years in Europe and Asia